Description
Introduction:
Intravenous solutions are the ones that are administered to a patient intravenously, directly through the circulatory system. These fluids must be sterile to protect patients from injury. Packaged intravenous fluids are manufacture by many companies, and their demand is increasing continuously.
The global IV solutions market is expected to reach USD 11,511.2 million by 2022 at a CAGR of 7.69% during the forecast period.
The global intravenous (IV) solution market has been segmented on the basis of type which comprises of total parenteral nutirtion, peripheral parenteral solution. Total parenteral nutrition segment accounted the largest market share in 2016.
On the basis of nutritional content the market is segmented into amino acid solution, carbohydrates, vitamins & minerals, parenteral lipid emulsion and others. Amino acid solution segment accounted the largest market share in 2016.
On the basis of end user the market is segmented into hospitals & clinics, ambulatory and others. Hospital & Clinics segment accounted the largest market share in 2016.
Key Players:
The leading market players in the global IV solutions market include ICU Medical, Inc. (U.S.), B. Braun Melsungen AG (Germany), Fresenius Kabi AG (Germany), Baxter (U.S.), Amanta Healthcare (India), Terumo Medical Corporation (Tokyo), Grifols S.A. (Spain) and others.
Study objectives of IV solutions market:
To provide insights about factors influencing and affecting the market growth.
To provide historical and forecast revenues of the market segments and sub-segments with respect to regional and country-level markets.
To provide historical and forecast revenue of the market segments based on types, products, applications, end users, and its sub-segments.
To provide strategic profiling of key players in the market, comprehensively analyzing their market share, core competencies, and drawing a competitive landscape for the market
Target Audience:
• Intravenous (IV) Solution Manufacturer
• Intravenous (IV) Solution Vendors
• Pharmaceutical & Biotechnology Companies
• Potential investors
• Key executive (CEO and COO) and strategy growth manager
Key Findings:
• The global Intravenous (IV) Solution market and is expected to reach USD 11,511.2 million by 2022.
• According to the type, Total Parenteral Nutrition (TPN) holds the largest market share of global Intravenous (IV) Solution market and is expected to reach USD 4,940.0 million in 2016.
• As per nutritional content, amino acid solution holds the largest market share of global intravenous (IV) Solution market is expected to reach USD 2,385.0 million in 2016.
The reports also cover country level analysis:
• America
• North America
• US
• Canada
• Latin America
• Europe
• Western Europe
• Germany
• France
• UK
• Italy
• Spain
• Rest Of Western Europe
• Eastern Europe
• Asia-Pacific
• Japan
• China
• India
• Republic of Korea
• Rest of Asia-Pacific
• Middle East & Africa
• UAE
• Saudi Arabia
• Egypt
• Rest of Middle East & Africa
1 Report Prologue
2 Introduction
2.1 Scope of Study
2.2 Research Objective
2.3 Assumptions & Limitations
2.3.1 Assumptions
2.3.2 Limitations
2.4 Market Structure
3 Research Methodology
3.1 Primary Research
3.2 Secondary Research
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Increasing Prevalence of the Chronic Diseases
4.2.2 Rise of Cholera
4.2.3 Growing acceptance of vitamin C intravenous for Colorectal Cancer
4.3 Restraints
4.3.1 Presence of Stringent Government Regulations
4.4 Opportunities
4.4.1 Rising continuous demand of IV solutions in U.S.
4.5 Challenge
4.5.1 Increasing Vitamin C Intravenous Therapy Prices
4.6 Mega Trends
4.7 Macroeconomic Indicators
5 Market Factor Analysis
5.1 Porters five forces analysis
5.1.1 Introduction
5.1.2 Bargaining Power of Suppliers
5.1.3 Bargaining Power of Buyers
5.1.4 Threat of Substitutes
5.1.5 Rivalry
5.1.6 Threat of New Entrants
5.2 Value chain Analysis
5.2.1 Introduction
5.2.2 Inputs
5.2.3 Research & Development
5.2.4 Development Stage
5.2.5 Manufacturing process of IV solutions
5.2.6 Marketing and Distribution
5.3 Demand Supply Gap Analysis
5.4 Price factor analysis
5.5 Investment Feasibility Analysis
6 Global IV Solution Market, By Types
6.1 Introduction
6.2 Peripheral Parenteral Nutrition
6.3 Total Parenteral Nutrition
7 Global IV Solution Market, By Nutritional Content
7.1 Introduction
7.2 Amino Acid Solution
7.3 Carbohydrates
7.4 Vitamins & minerals
7.5 Parenteral lipid emulsion
7.6 Other Solutions
8 Global IV Solution Market, By End Users
8.1 Introduction
8.2 Hospital & Clinics
8.3 Ambulatory
8.4 Home Care
9 Global IV Solution Market, By Regions
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 France
9.3.3 Italy
9.3.4 UK
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Republic of Korea
9.4.5 Australia
9.4.6 Rest of Asia Pacific
9.5 Middle East & Africa
9.5.1 UAE
9.5.2 Saudi Arabia
9.5.3 Egypt
9.5.4 Rest of Middle East & Africa
10 Company Share Analysis
11 Company Profiles
11.1 Baxter
11.1.1 Company Overview
11.1.2 Product/Business Segment Overview
11.1.3 Financial Overview
11.1.4 Key Development
11.1.5 SWOT Analysis
11.2 Fresenius Group
11.2.1 Company Overview
11.2.2 Product/Business Segment Overview
11.2.3 Financial Overview
11.2.4 Key Development
11.2.5 SWOT Analysis
11.3 Braun Melsungen AG
11.3.1 Overview
11.3.2 Product/Business Segment Overview
11.3.3 Financial Updates
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 ICU Medical, Inc.
11.4.1 Company overview
11.4.2 Product Overview
11.4.3 Financials
11.4.4 Key Developments
11.4.5 SWOT Analysis
11.5 Grifols S.A
11.5.1 Company Overview
11.5.2 Product Overview
11.5.3 Financial Overview
11.5.4 Key Development
11.5.5 SWOT Analysis
11.6 Terumo Medical Corporation
11.6.1 Company Overview
11.6.2 Product Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 Amanta Healthcare
11.7.1 Company Overview
11.7.2 Product Overview
11.7.3 Financial Overview
11.7.4 Key Developments
11.7.5 SWOT Analysis
12 MRFR Conclusion
12.1 Key Findings
12.1.1 From CEO’s View Point
12.1.2 Unmet Needs
12.2 Key companies to watch
13 Appendix
13.1 Discussion Blue Print
13.2 References
TABLE 1 GLOBAL IV SOLUTIONS MARKET, BY TYPES USD MILLION (2014-2022)
TABLE 2 GLOBAL PERIPHERAL PARENTERAL NUTRITION MARKET BY REGION USD MILLION (2014-2022)
TABLE 3 GLOBAL TOTAL PARENTERAL NUTRITION MARKET BY REGION USD MILLION (2014-2022)
TABLE 4 GLOBAL IV SOLUTIONS MARKET, BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 5 GLOBAL AMINO ACID SOLUTION MARKET BY REGION USD MILLION (2014-2022)
TABLE 6 GLOBAL CARBOHYDRATES MARKET BY REGION USD MILLION (2014-2022)
TABLE 7 GLOBAL VITAMINS & MINERALS MARKET BY REGION USD MILLION (2014-2022)
TABLE 8 GLOBAL PARENTERAL LIPID EMULSION MARKET BY REGION USD MILLION (2014-2022)
TABLE 9 GLOBAL OTHER SOLUTIONS MARKET BY REGION USD MILLION (2014-2022)
TABLE 10 GLOBAL IV SOLUTIONS MARKET, BY END USERS USD MILLION (2014-2022)
TABLE 11 GLOBAL HOSPITAL & CLINICS MARKET BY REGION USD MILLION (2014-2022)
TABLE 12 GLOBAL AMBULATORY MARKET BY REGION USD MILLION (2014-2022)
TABLE 13 GLOBAL HOME CARE MARKET BY REGION USD MILLION (2014-2022)
TABLE 14 GLOBAL IV SOLUTIONS MARKET, BY REGION USD MILLION (2014-2022)
TABLE 15 NORTH AMERICA IV SOLUTIONS MARKET BY, COUNTRY USD MILLION (2014-2022)
TABLE 16 NORTH AMERICA IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 17 NORTH AMERICA IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 18 NORTH AMERICA IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 19 US IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 20 US IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 21 US IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 22 CANADA IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 23 CANADA IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 24 CANADA IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 25 EUROPE IV SOLUTIONS MARKET BY, COUNTRY USD MILLION (2014-2022)
TABLE 26 EUROPE IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 27 EUROPE IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 28 EUROPE IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 29 GERMANY IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 30 GERMANY IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 31 GERMANY IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 32 FRANCE IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 33 FRANCE IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 34 FRANCE IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 35 ITALY IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 36 ITALY IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 37 ITALY IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 38 UK IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 39 UK IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 40 UK IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 41 SPAIN IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 42 SPAIN IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 43 SPAIN IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 44 REST OF EUROPE IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 45 REST OF EUROPE IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 46 REST OF EUROPE IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 47 ASIA PACIFIC IV SOLUTIONS MARKET BY, COUNTRY USD MILLION (2014-2022)
TABLE 48 ASIA PACIFIC IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 49 ASIA PACIFIC IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 50 ASIA PACIFIC IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 51 JAPAN IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 52 JAPAN IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 53 JAPAN IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 54 CHINA IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 55 CHINA IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 56 CHINA IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 57 INDIA IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 58 INDIA IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 59 INDIA IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 60 REPUBLIC OF KOREA IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 61 REPUBLIC OF KOREA IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 62 REPUBLIC OF KOREA IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 63 AUSTRALIA IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 64 AUSTRALIA IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 65 AUSTRALIA IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 66 REST OF ASIA PACIFIC IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 67 REST OF ASIA PACIFIC IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 68 REST OF ASIA PACIFIC IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 69 MIDDLE EAST & AFRICA IV SOLUTIONS MARKET BY, COUNTRY USD MILLION (2014-2022)
TABLE 70 MIDDLE EAST & AFRICA IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 71 MIDDLE EAST & AFRICA IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 72 MIDDLE EAST & AFRICA IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 73 UAE IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 74 UAE IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 75 UAE IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 76 SAUDI ARABIA IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 77 SAUDI ARABIA IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 78 SAUDI ARABIA IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 79 EGYPT IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 80 EGYPT IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 81 EGYPT IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 82 REST OF MIDDLE EAST & AFRICA IV SOLUTIONS MARKET BY TYPES USD MILLION (2014-2022)
TABLE 83 REST OF MIDDLE EAST & AFRICA IV SOLUTIONS MARKET BY NUTRITIONAL CONTENT USD MILLION (2014-2022)
TABLE 84 REST OF MIDDLE EAST & AFRICA IV SOLUTIONS MARKET BY END USERS USD MILLION (2014-2022)
TABLE 85 BAXTER: KEY DEVELOPMENT
TABLE 86 FRESENIUS KABI AG: KEY DEVELOPMENT
TABLE 87 BRAUN MELSUNGEN AG: KEY DEVELOPMENT
TABLE 88 ICU MEDICAL INC.: KEY DEVELOPMENT
TABLE 89 GRIFOLS S.A.: KEY DEVELOPMENTS
TABLE 90 TERUMO MEDICAL CORPORATION: KEY DEVELOPMENTS 115
FIGURE 1 GLOBAL IV SOLUTIONS MARKET, BY TYPE, 2016 (%)
FIGURE 2 GLOBAL IV SOLUTIONS MARKET, BY NUTRITIONAL CONTENT, 2016 (%)
FIGURE 3 GLOBAL IV SOLUTIONS MARKET, BY END USER, 2016 (%)
FIGURE 4 GLOBAL IV SOLUTIONS MARKET, BY REGION, 2016 (%)
FIGURE 5 GLOBAL IV SOLUTIONS: MARKET STRUCTURE
FIGURE 6 RESEARCH PROCESS
FIGURE 7 GLOBAL IV SOLUTIONS MARKET: MARKET DYNAMICS
FIGURE 8 GROWTH DRIVERS: IMPACT ANALYSIS
FIGURE 9 GLOBAL IV SOLUTIONS MARKET, BY TYPES USD MILLION (2016 & 2022)
FIGURE 10 GLOBAL IV SOLUTIONS MARKET, BY NUTRITIONAL CONTENT USD MILLION (2016 & 2022)
FIGURE 11 GLOBAL IV SOLUTIONS MARKET, BY END USERS USD MILLION (2016 & 2022)
FIGURE 12 GLOBAL IV SOLUTIONS MARKET, BY REGION USD MILLION (2016 & 2022)
FIGURE 13 NORTH AMERICA IV SOLUTIONS MARKET BY, COUNTRY MARKET SHARE 2016 (%)
FIGURE 14 EUROPE IV SOLUTIONS MARKET BY, COUNTRY MARKET SHARE 2016 (%)
FIGURE 15 ASIA PACIFIC IV SOLUTIONS MARKET BY, COUNTRY MARKET SHARE 2016 (%)
FIGURE 16 MIDDLE EAST & AFRICA IV SOLUTIONS MARKET BY, COUNTRY MARKET SHARE 2016 (%)
FIGURE 17 COMPANY SHARE ANALYSIS
FIGURE 18 BAXTER: RECENT FINANCIAL: REVENUE (US$ MILLION) & R&D EXPENSES (%)
FIGURE 19 BAXTER: GEOGRAPHICAL MIX
FIGURE 20 BAXTER: OPERATING SEGMENTS
FIGURE 21 BAXTER: HOSPITAL PRODUCTS SEGMENT REVENUE
FIGURE 22 BAXTER: SWOT ANALYSIS
FIGURE 23 FRESENIUS GROUP: RECENT FINANCIAL: REVENUE (EURO MILLION) & R&D EXPENSES (%)
FIGURE 24 FRESENIUS GROUP: GEOGRAPHICAL MIX
FIGURE 25 FRESENIUS GROUP: OPERATING SEGMENTS
FIGURE 26 FRESENIUS GROUP: FRESENIUS KABI SEGMENT REVENUE
FIGURE 27 FRESENIUS KABI AG: SWOT ANALYSIS
FIGURE 28 BRAUN MELSUNGEN AG: RECENT FINANCIAL: REVENUE (US$ MILLION) & R&D EXPENSES (%)
FIGURE 29 BRAUN MELSUNGEN AG: BUSINESS REVENUE
FIGURE 30 BRAUN MELSUNGEN AG: B.BRAUN HOSPITAL CARE SEGMENT REVENUE
FIGURE 31 BRAUN MELSUNGEN AG: GEOGRAPHICAL REVENUE
FIGURE 32 BRAUN MELSUNGEN AG: SWOT ANALYSIS
FIGURE 33 ICU MEDICAL, INC: RECENT FINANCIAL: REVENUE (US$ MILLION) & R&D EXPENSES (%)
FIGURE 34 ICU MEDICAL, INC: GEOGRAPHICAL MIX
FIGURE 35 ICU MEDICAL, INC: SEGMENTAL MIX
FIGURE 36 ICU MEDICAL, INC.: INFUSION THERAPY SEGMENT REVENUE
FIGURE 37 ICU MEDICAL, INC: SWOT ANALYSIS
FIGURE 38 GRIFOLS S.A FINANCIAL OVERVIEW: RECENT FINANCIAL: REVENUE (US$ MILLION)
FIGURE 39 GRIFOLS S.A: RECENT FINANCIAL: OPERATING SEGMENTS
FIGURE 40 GRIFOLS S.A.: HOSPITAL SEGMENT REVENUE
FIGURE 41 GRIFOLS S.A FINANCIAL OVERVIEW: GEOGRAPHICAL REVENUE
FIGURE 42 SWOT ANALYSIS GRIFOLS S.A
FIGURE 43 TERUMO MEDICAL CORPORATION: RECENT FINANCIAL: REVENUE (US$ MILLION) & R&D EXPENSES (%)
FIGURE 44 TERUMO MEDICAL CORPORATION FINANCIAL OVERVIEW SEGMENTAL OVERVIEW
FIGURE 45 TERUMO MEDICAL CORPORATION: GENERAL HOSPITAL COMPANY SEGMENT REVENUE
FIGURE 46 TERUMO MEDICAL CORPORATION FINANCIAL OVERVIEW: GEOGRAPHICAL REVENUE
FIGURE 47 TERUMO MEDICAL CORPORATION FINANCIAL OVERVIEW GEOGRAPHICAL OVERVIEW
FIGURE 48 SWOT ANALYSIS
